ATE79261T1 - Verfahren zur behandlung von magen-darmstoerungen. - Google Patents

Verfahren zur behandlung von magen-darmstoerungen.

Info

Publication number
ATE79261T1
ATE79261T1 AT86304409T AT86304409T ATE79261T1 AT E79261 T1 ATE79261 T1 AT E79261T1 AT 86304409 T AT86304409 T AT 86304409T AT 86304409 T AT86304409 T AT 86304409T AT E79261 T1 ATE79261 T1 AT E79261T1
Authority
AT
Austria
Prior art keywords
treatment
methods
subject
gastrointestinal disorders
campylobacter
Prior art date
Application number
AT86304409T
Other languages
English (en)
Inventor
Barry James M D Marshall
Original Assignee
Barry James M D Marshall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24994180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE79261(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Barry James M D Marshall filed Critical Barry James M D Marshall
Application granted granted Critical
Publication of ATE79261T1 publication Critical patent/ATE79261T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AT86304409T 1985-06-13 1986-06-10 Verfahren zur behandlung von magen-darmstoerungen. ATE79261T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74484285A 1985-06-13 1985-06-13
EP86304409A EP0206627B1 (de) 1985-06-13 1986-06-10 Verfahren zur Behandlung von Magen-Darmstörungen

Publications (1)

Publication Number Publication Date
ATE79261T1 true ATE79261T1 (de) 1992-08-15

Family

ID=24994180

Family Applications (2)

Application Number Title Priority Date Filing Date
AT86304409T ATE79261T1 (de) 1985-06-13 1986-06-10 Verfahren zur behandlung von magen-darmstoerungen.
AT86304408T ATE79264T1 (de) 1985-06-13 1986-06-10 Verwendung von bismuth zur herstellung von medikamenten zur behandlung von magendarmst¯rungen, die von campylobacter polyridis verursacht sind.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT86304408T ATE79264T1 (de) 1985-06-13 1986-06-10 Verwendung von bismuth zur herstellung von medikamenten zur behandlung von magendarmst¯rungen, die von campylobacter polyridis verursacht sind.

Country Status (8)

Country Link
US (1) US5601848A (de)
EP (2) EP0206627B1 (de)
JP (1) JPH0794391B2 (de)
AT (2) ATE79261T1 (de)
BE (1) BE904922A (de)
DE (4) DE3686361T3 (de)
IE (2) IE59584B1 (de)
PH (1) PH26891A (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG72632A1 (en) * 1985-04-18 2000-05-23 Procter & Gamble Treatment of non-ulcer dyspepsia with bismuth salts
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3874917T2 (de) * 1987-03-09 1993-03-04 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
WO1989003219A1 (en) * 1987-10-12 1989-04-20 Borody Thomas J Improved method for treatment of gastrointestinal disorders
EP0348143A3 (de) * 1988-06-21 1991-03-13 MARION LABORATORIES, INC. (a Delaware corporation) Bismuth-Derivate von Saccharid-Phosphaten und Sulfaten
US4935406A (en) * 1988-09-20 1990-06-19 Marion Laboratories, Inc. Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders
ES2040307T3 (es) * 1988-10-08 1993-10-16 Dr. R. Pfleger Chemische Fabrik Gmbh Procedimiento para producir un preparado medicamentoso liquido que contiene bismuto.
DE3901508C2 (de) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
NL9220019A (nl) * 1992-04-10 1994-04-05 Vnii Med Polimerov Farmaceutische samenstelling.
US5376553A (en) * 1993-06-18 1994-12-27 University Of Florida Clinical marker and therapeutic agent in kidney stone disease and methods of use
AU7833194A (en) * 1993-09-20 1995-04-10 Procter & Gamble Company, The Use of triclosan phosphates for the treatment of gastrointestinal disorders due to heliobacter infection
WO1995012579A1 (en) * 1993-11-05 1995-05-11 Otsuka Pharmaceutical Company, Limited Bismuth salt of carbostyril derivatives for the treatment of peptic ulcers
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US5607964A (en) * 1994-06-17 1997-03-04 University Of Florida Clinical marker and therapeutic agent in kidney stone disease and methods of use
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
BR9611913A (pt) * 1995-12-07 1999-03-02 Procter & Gamble Composições contendo bismuto para a prevenção e tratamento de distúrbios gastrintestinais
US5702729A (en) * 1995-12-07 1997-12-30 The Procter & Gamble Company Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria
GB9623962D0 (en) * 1996-11-15 1997-01-08 Tillotts Pharma Ag Pharmaceutical composition
US6186958B1 (en) 1997-02-26 2001-02-13 Oridion Medical Breath test analyzer
MX9703918A (es) 1997-05-28 1998-11-30 J Marshall M D Barry Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
USRE38728E1 (en) * 1997-09-11 2005-04-19 Oridion Medical, LTD Breath test analyzer
USD467348S1 (en) 2001-10-15 2002-12-17 Kimberly-Clark Worldwide, Inc. Diagnostic test carrier
US6929926B2 (en) 2001-10-15 2005-08-16 Barry J. Marshall Composition for the detection of gastrointestinal disorders
US20030072686A1 (en) * 2001-10-15 2003-04-17 Marshall Barry J. Systems for performing multiple diagnostic tests
US20030073155A1 (en) * 2001-10-15 2003-04-17 Mcmichael Donald J. Methods for performing multiple diagnostic tests
US6998250B2 (en) 2001-10-15 2006-02-14 Donald J. McMichael Method for detecting Helicobacter pylori
US7008777B2 (en) * 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
USD485359S1 (en) 2001-10-15 2004-01-13 Kimberly-Clark Worldwide, Inc. Specimen-handling tool
USD470241S1 (en) 2001-12-17 2003-02-11 Kimberly-Clark Worldwide, Inc. Specimen-handling tool
USD470597S1 (en) 2001-12-17 2003-02-18 Kimberly-Clark Worldwide, Inc. Diagnostic test kit
USD471639S1 (en) 2001-12-17 2003-03-11 Kimberly-Clark Worldwide, Inc. Tool for handling a specimen
USD484988S1 (en) 2001-12-17 2004-01-06 Kimberly-Clark Worldwide, Inc. Diagnostic test kit with specimen-handling tool
USD470596S1 (en) 2001-12-17 2003-02-18 Kimberly-Clark Worldwide, Inc. Test kit specimen-handling tool
USD469881S1 (en) 2001-12-17 2003-02-04 Kimberly-Clark Worldwide, Inc. Two-well diagnostic test kit with specimen-handling tool
US6783976B2 (en) 2001-12-21 2004-08-31 Kimberly-Clark Worldwide, Inc. Carrier and specimen-handling tool for use in diagnostic testing
US20040086532A1 (en) * 2002-11-05 2004-05-06 Allergan, Inc., Botulinum toxin formulations for oral administration
WO2007090113A2 (en) 2006-02-01 2007-08-09 Weg Stuart L Use of antifungal compositions to treat upper gastrointestinal conditions
FR2913403B1 (fr) 2007-03-05 2009-05-29 Astrium Sas Soc Par Actions Si Commande d'actionneur reduisant le niveau de vibrations d'une structure flexible associee
JP2015504881A (ja) * 2011-12-20 2015-02-16 ギリアード サイエンシーズ， インコーポレイテッド 胃腸感染および障害を処置するための医薬組成物および方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301743A (de) * 1962-12-13
FR4961M (de) * 1965-03-29 1967-04-03
FR5877M (de) * 1966-07-22 1968-03-18
FR6197M (de) * 1967-04-12 1968-07-22
US3577533A (en) * 1968-02-21 1971-05-04 Joseph Alfred Rider Antacid compositions containing bismuth aluminate and coprecipitated aluminum hydroxide and magnesium carbonate
US4153685A (en) * 1968-11-23 1979-05-08 Schering Corporation Bismuth complex preparations
FR2053002A1 (en) * 1969-06-21 1971-04-16 Clin Midy Bismuth slats of alpha methiminobenzyl - penicillin
DE1963496A1 (de) * 1969-12-18 1971-06-24 Hans Voigt Chemisch Pharmazeut Pharmazeutisches Praeparat zur Behandlung von Magen-Darm-Erkrankungen
US4118480A (en) * 1973-02-09 1978-10-03 Charles V. Stoelker Pharmaceutical preparation for treating hemorrhoids and anal fissures
ZA74385B (en) * 1974-01-18 1975-08-27 Gist Brocades Nv Pharmaceutical compositions
US4016268A (en) * 1975-10-06 1977-04-05 Morton-Norwich Products, Inc. Method of combatting gastric ulceration
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
US4588589A (en) * 1983-10-13 1986-05-13 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof

Also Published As

Publication number Publication date
BE904922A (fr) 1986-12-15
PH26891A (en) 1992-11-03
IE861574L (en) 1986-12-13
DE3686362D1 (de) 1992-09-17
EP0206626B2 (de) 2002-05-22
JPS6248624A (ja) 1987-03-03
IE59585B1 (en) 1994-03-09
EP0206626A2 (de) 1986-12-30
ATE79264T1 (de) 1992-08-15
EP0206626B1 (de) 1992-08-12
DE3686362T2 (de) 1993-02-11
EP0206627A3 (en) 1989-04-05
IE861573L (en) 1986-12-13
EP0206627B1 (de) 1992-08-12
JPH0794391B2 (ja) 1995-10-11
IE59584B1 (en) 1994-03-09
DE3686361T2 (de) 1993-02-11
DE3619733A1 (de) 1987-02-12
DE3686361T3 (de) 2003-01-09
US5601848A (en) 1997-02-11
DE3686361D1 (de) 1992-09-17
EP0206627A2 (de) 1986-12-30
EP0206626A3 (en) 1989-04-12
DE3619734A1 (de) 1987-02-12

Similar Documents

Publication Publication Date Title
ATE79261T1 (de) Verfahren zur behandlung von magen-darmstoerungen.
DE58906894D1 (de) Einrichtung zur diagnostik und behandlung von nasenerkrankungen.
DE69307509D1 (de) Vorrichtung zur behandlung von herzfehlern
DE69334246D1 (de) Verbesserte reagentien und methoden zur diagnose und behandlung von diabetes und stiff man syndrome
DE3888273D1 (de) Medizinischer Apparat zur Behandlung mit Ultraschall.
DE3789642D1 (de) Apparat zur iontophoretischen behandlung mit medikamenten.
ATE130762T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
NO873753D0 (no) Periodisk biologisk luftbehandlingsprosess og system for denne.
DE3788815D1 (de) Erntemaschine für Feldfrüchte und Verfahren.
DE3875575D1 (de) Verfahren und vorrichtung und vorrichtung zur herstellung und behandlung von transfermembranen.
DE68910175D1 (de) Adsorbermodul sowie Adsorberapparat zur Behandlung von Vollblut.
DE3786893D1 (de) Piperidinderivat zur schmerzbehandlung.
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
ATE80519T1 (de) Vorrichtung zur transcuticularen applikation von wirkstoffen an pflanzen.
DE3686097D1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
FI901371A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten halogeeni-3,4-dihydro-bentsotiopyranyyliamiinien valmistamiseksi
DE3674213D1 (de) Verfahren zur herstellung von keimabgetoeteten oder in ihrer virulenz abgeschwaechten substanzen sowie deren verwendung.
PT76582B (de) 1,2,4-triazol-1-yl-propionitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
ATE128188T1 (de) Menschliches gamma-interferon, verfahren zu seiner herstellung und seine verwendung.
ATE136463T1 (de) Verwendung von 1,2,3,4-tetrahydroacridinen zur behandlung von aids, sowie verbindungen
ATE101054T1 (de) Einrichtung zur diagnostik und behandlung von nasenerkrankungen.
DE3483046D1 (de) Heubehandlungsverfahren und vorrichtung.
UA19794A (uk) Спосіб моделюваhhя виразки шлуhку
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
ATE38467T1 (de) Verfahren zur stimulation des menschlichen vestibularapparates und vorrichtung hierfuer.

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time